New Provisions for EU-UK Prescribed drugs

New Provisions for EU-UK Pharmaceuticals

The British Parliament and the EU Commission have now agreed a comprehensive trade and cooperation agreement between the EU and Great Britain that focuses on the delivery of goods. Medicines are highlighted in a number of areas. For example, Annex TBT-2 of the agreement provides for the recognition of Good Manufacturing Practice (GMP) inspections of … Read more

Scott+Scott Attorneys at Regulation LLP Continues Investigation of Regeneron Prescription drugs, Inc.’s Administrators and Officers for Breach of Fiduciary Obligation – REGN

Scott+Scott Attorneys at Law LLP Continues Investigation of Regeneron Pharmaceuticals, Inc.’s Directors and Officers for Breach of Fiduciary Duty – REGN

NEW YORK–(BUSINESS WIRE) – Scott + Scott Lawyers LLP (“Scott + Scott”), a national securities and consumer litigation firm, is continuing its investigation into whether certain directors and officers of Regeneron Pharmaceuticals, Inc. (“Regeneron”) (NASDAQ: REGN) have violates their duties of loyalty to Regeneron and its shareholders. If you are a Regeneron shareholder, please contact … Read more

Brexit Impacts on Commerce: Aid for Prescription drugs and Recommendation for Contracting

Brexit Impacts on Trade: Relief for Pharmaceuticals and Advice for Contracting

Brexit threatens to have a significant impact on the import and export of goods and services from the UK. Recent legislative moves have freed up more time to implement the Medicines Regulation in Northern Ireland so companies can prepare for batch screening, importation and counterfeit medicines directive requirements, like Adrian Spooner on our blog on … Read more